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Tobacco use in high-income countries correlates with socio-economic disadvantage; 
groups vulnerable to disadvantage who also have high smoking prevalence include 
people who are homeless or in the prison system, those who have a mental illness or 
a drug or alcohol addiction, and the indigenous people of North America and 
Australasia (Twyman et al., 2014). In addition, pregnant women and young people 
are often regarded as vulnerable groups because of the importance of halting the 
tobacco epidemic in future generations (Notley et al., 2015). A recent systematic 
review found that barriers to smoking cessation included smoking for stress 
management, lack of support from health and other service providers and high 
prevalence and acceptability of smoking in vulnerable communities (Twyman et al., 
2014). However, while similar findings have been reported in many other studies and 
reviews, they have not resulted in widespread implementation of effective 
interventions to address continuing high rates of smoking in these groups. We need 
greater understanding of why tobacco control strategies have not reached or 
impacted upon vulnerable groups; but to reduce smoking-related health inequalities 
quickly, we also need alternative approaches. 
One potentially promising approach to supporting smoking cessation in vulnerable 
groups may be tobacco harm reduction. This involves replacing very harmful tobacco 
products with far less risky alternatives that contain nicotine, the addictive 
constituent in smoked tobacco, but without many of the harmful constituents of 
cigarettes. Although the idea of addiction is contested and fraught with moral 
judgement (Bell and Keane, 2012), particularly for groups which are already the 
focus of stigma (Graham, 2012), higher levels of addiction in vulnerable populations 
(Siahpush et al., 2006) suggest that they might disproportionately benefit from a 
harm reduction approach involving the continued use of nicotine. In addition to 
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nicotine,  less risky products may provide alternative sources of social identity and 
pleasure (Notley et al., 2018, Cox and Jakes, 2017, Barbeau et al., 2013), replacing 
aspects of smoking which quitters might miss as much or more than the nicotine 
itself. Key current alternative products include e-cigarettes or vaping products, which 
existing evidence suggests are substantially less harmful to health than continued 
tobacco smoking (National Academies of Sciences, 2018, McNeill et al., 2018). In the 
UK, a recent UK Parliamentary Select Committee Report on e-cigarettes endorsed 
their use in vulnerable groups e.g. patients in mental health units (Science & 
Technology Select Committee, 2018).  However, other countries, including Australia 
and the US, have been, and may increasingly be, more concerned with young 
peoples potential exposure to e-cigarettes than with the benefits to smokers (Green 
et al., 2016), whilst others, despite having many poor smokers, have taken a hostile 
approach (Cousins, 2018).
It is not yet clear to what extent e-cigarettes will be effective in vulnerable groups 
(Gentry et al., 2018), nor how they will impact on health inequalities (Lucherini et al., 
2018, Thirlway, 2018), not least because some barriers to e-cigarette use may affect 
vulnerable groups disproportionately. These include initial start-up costs and other 
difficulties in accessing and operating devices and refills, the masculine environment 
of vape shops which may be off-putting to women smokers, legal limits on nicotine 
concentrations and concerns about health risks and continuing addiction, often 
linked to the regulatory environment (Thirlway, 2016, Cox et al., 2018, Gentry et al., 
2018, Ward et al., 2018, Dawkins et al., 2018, Yong et al., 2017). Health care 
professionals have been reluctant to support e-cigarette use during pregnancy due 
to safety concerns, and tobacco smoking has historically been part of the culture of 
inpatient psychiatric services (Trainor and Leavey, 2016). Many of these barriers can 
be addressed by public health policy, driven in the UK by the Public Health England 
evidence review of e-cigarettes (McNeill at al 2018) but also put into practice by 
smoking cessation services supporting e-cigarette use (e.g. Leicester Stop Smoking 
Service).  South London and Maudsley NHS Foundation Trust and Norfolk and Suffolk 
Mental Health Trust have adopted e-cigarette friendly services. In the UK, the 
Mental Health and Smoking Partnership has produced resources including advice on 
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e-cigarettes for mental health settings (Smoke Free Action, 2018b). Similarly, the 
smoking in pregnancy challenge group (Smoke Free Action, 2018a) has been at the 
forefront of developing evidence-based advice for pregnant women and healthcare 
professionals to promote engagement with e-cigarettes as a reduced harm 
alternative to continued cigarette smoking.   The extent to which such initiatives are 
successful in addressing high rates of smoking in vulnerable populations is an 
emergent area for international research, where contextual factors including policy 
and culture fundamentally influence the implementation of reduced harm 
approaches to nicotine addiction.
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